Infectious Disease Research.
Our MPV and other experimental cells, produced with regenerative medicine technologies, will solve the shortage of experimental cells for researches on malaria and other infectious diseases, and help researchers accelerate their experiments exponentially.
* We are now providing test
and pilot products and will
start full-scale production in 2018.
red blood-like cells for
myeloid lineage cells for
Dengue and other infectious diseases